tiprankstipranks
Trending News
More News >
Soleno Therapeutics Inc (SLNO)
NASDAQ:SLNO
US Market

Soleno Therapeutics (SLNO) Financial Statements

Compare
921 Followers

Soleno Therapeutics Financial Overview

Soleno Therapeutics's market cap is currently $2.02B. The company's EPS TTM is $0.8; its P/E ratio is 175.28; Soleno Therapeutics is scheduled to report earnings on February 25, 2026, and the estimated EPS forecast is $0.67. See an overview of income statement, balance sheet, and cash flow financials.
Dec 25Dec 24Dec 23Dec 22Mar 22
Income Statement
Total Revenue$ 190.41M$ 0.00$ 0.00$ 0.00$ 0.00
Gross Profit$ 187.71M$ 0.00$ -1.96M$ 0.00$ 0.00
Operating Income$ 14.95M$ -187.67M$ -41.38M$ -24.40M$ -31.53M
EBITDA$ 28.38M$ -173.63M$ -37.03M$ -22.10M$ -30.30M
Net Income$ 20.89M$ -175.85M$ -38.99M$ -24.07M$ -30.91M
Balance Sheet
Cash & Short-Term Investments$ 305.47M$ 291.44M$ 169.68M$ 14.60M$ 21.30M
Total Assets$ 563.83M$ 330.97M$ 180.69M$ 26.50M$ 35.55M
Total Debt$ 2.69M$ 52.83M$ 403.00K$ 155.00K$ 457.00K
Net Debt$ -67.42M$ -35.10M$ -169.28M$ -14.45M$ -20.85M
Total Liabilities$ 113.72M$ 85.86M$ 23.18M$ 16.15M$ 17.76M
Stockholders' Equity$ 450.12M$ 245.11M$ 157.51M$ 10.35M$ 17.79M
Cash Flow
Free Cash Flow$ 46.73M$ -69.31M$ -24.94M$ -20.79M$ -27.79M
Operating Cash Flow$ 46.80M$ -69.10M$ -24.94M$ -20.78M$ -27.77M
Investing Cash Flow$ -201.78M$ -225.68M$ 0.00$ -13.00K$ -22.00K
Financing Cash Flow$ 137.16M$ 213.03M$ 180.02M$ 14.09M$ -128.00K
Currency in USD

Soleno Therapeutics Earnings and Revenue History

Soleno Therapeutics Debt to Assets

Soleno Therapeutics Cash Flow

Soleno Therapeutics Forecast EPS vs Actual EPS